These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4030996)

  • 1. Assessment of specific virus infectivity and virus neutralization by a progeny virus immunotitration method as exemplified in an adenovirus system.
    Wohlfart CE; Everitt E
    J Virol Methods; 1985 Jul; 11(3):241-51. PubMed ID: 4030996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipeptide antisera define neutralizing epitopes on the adenovirus hexon.
    Toogood CI; Crompton J; Hay RT
    J Gen Virol; 1992 Jun; 73 ( Pt 6)():1429-35. PubMed ID: 1376769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human adenovirus 2 as immunogen in rabbits yields antisera with high titers of antibodies against the nonstructural 72K DNA-binding protein.
    Wohlfart C; Everitt E
    Virus Res; 1985 Jul; 3(1):77-85. PubMed ID: 4040685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between HeLa cells and adenovirus type 2 virions neutralized by different antisera.
    Wohlfart CE; Svensson UK; Everitt E
    J Virol; 1985 Dec; 56(3):896-903. PubMed ID: 4068145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of an antigenic adenovirus epitope in a group B coxsackievirus.
    Höfling K; Tracy S; Chapman N; Kim KS; Smith Leser J
    J Virol; 2000 May; 74(10):4570-8. PubMed ID: 10775593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased infectivity of extracellular adenovirus type 12.
    Brüggemann U; Klenk HD; Doerfler W
    J Virol; 1985 Jul; 55(1):117-25. PubMed ID: 4009790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralization of adenovirus infectivity and cytotoxin in various cell cultures.
    Schrader E; Wigand R
    J Virol Methods; 1981 Jun; 2(6):321-30. PubMed ID: 7021571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of human adenovirus serotype 2 with human lymphoid cells.
    Silver L; Anderson CW
    Virology; 1988 Aug; 165(2):377-87. PubMed ID: 3407148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a Critical and Conformational Neutralizing Epitope in Human Adenovirus Type 4 Hexon.
    Tian X; Qiu H; Zhou Z; Wang S; Fan Y; Li X; Chu R; Li H; Zhou R; Wang H
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postentry neutralization of adenovirus type 5 by an antihexon antibody.
    Varghese R; Mikyas Y; Stewart PL; Ralston R
    J Virol; 2004 Nov; 78(22):12320-32. PubMed ID: 15507619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralizing antibodies against adenovirus type 2 in normal and HIV-1-infected subjects: Implications for use of Ad2 vectors in vaccines.
    Li Q; Liu Q; Huang W; Song A; Zhao C; Wu J; Wang Y
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-8. PubMed ID: 28301274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular biology of adenovirus type 2 semipermissive infections. I. Viral growth and expression of viral replicative functions during restricted adenovirus infection.
    Eggerding FA; Pierce WC
    Virology; 1986 Jan; 148(1):97-113. PubMed ID: 3942035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of a foreign epitope on the surface of the adenovirus hexon.
    Crompton J; Toogood CI; Wallis N; Hay RT
    J Gen Virol; 1994 Jan; 75 ( Pt 1)():133-9. PubMed ID: 7509367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virus-receptor interaction in the adenovirus system I. Identification of virion attachment proteins of the HeLa cell plasma membrane.
    Svensson U; Persson R; Everitt E
    J Virol; 1981 Apr; 38(1):70-81. PubMed ID: 7241661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo.
    O'Riordan CR; Lachapelle A; Delgado C; Parkes V; Wadsworth SC; Smith AE; Francis GE
    Hum Gene Ther; 1999 May; 10(8):1349-58. PubMed ID: 10365665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of cellular adhesion sequences in the attachment of adenovirus to the HeLa cell surface.
    Belin MT; Boulanger P
    J Gen Virol; 1993 Aug; 74 ( Pt 8)():1485-97. PubMed ID: 8345346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-size recombinant adenoviral hexon protein fragments for the production of virus-type specific antibodies.
    Pacesa M; Hendrickx R; Bieri M; Flatt JW; Greber UF; Hemmi S
    Virol J; 2017 Aug; 14(1):158. PubMed ID: 28821267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virion-targeted viral inactivation: new therapy against viral infection.
    Okui N; Kitamura Y; Kobayashi N; Sakuma R; Ishikawa T; Kitamura T
    Mol Urol; 2001; 5(2):59-66. PubMed ID: 11690549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonpermissivity of human peripheral blood lymphocytes to adenovirus type 2 infection.
    Horvath J; Weber JM
    J Virol; 1988 Jan; 62(1):341-5. PubMed ID: 3334747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propagation and in vitro studies of previously non-cultivable enteral adenoviruses in 293 cells.
    Takiff HE; Straus SE; Garon CF
    Lancet; 1981 Oct; 2(8251):832-4. PubMed ID: 6116953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.